Header cover image

U.S. Pharma Industry Analysis

UpdatedJun 07, 2023
DataAggregated Company Financials
Companies322
  • 7D3.0%
  • 3M7.6%
  • 1Y-1.5%
  • YTD-3.9%

In the last week, the Pharma industry is up 3.0%, with Eli Lilly up 3.7%. Meanwhile, Bausch Health Companies actually underperformed within the industry, shrinking 11% in the last week. Overall in the last year, the industry is flat. Earnings are forecast to grow by 14% annually.

Industry Valuation and Performance

Has the U.S. Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 07 Jun 2023US$1.7tUS$393.0bUS$60.5b18.8x28.3x4.4x
Fri, 05 May 2023US$1.7tUS$392.9bUS$59.5b19.2x28.7x4.3x
Sun, 02 Apr 2023US$1.6tUS$401.2bUS$69.5b15.1x22.7x3.9x
Tue, 28 Feb 2023US$1.6tUS$401.8bUS$68.4b17.7x22.9x3.9x
Thu, 26 Jan 2023US$1.7tUS$402.6bUS$69.4b17.6x24.4x4.2x
Sat, 24 Dec 2022US$1.8tUS$403.7bUS$70.7b16.8x24.8x4.4x
Mon, 21 Nov 2022US$1.7tUS$403.7bUS$70.6b14.2x24.4x4.3x
Wed, 19 Oct 2022US$1.6tUS$403.0bUS$71.3b13.1x22.6x4x
Fri, 16 Sep 2022US$1.6tUS$403.0bUS$71.3b13.7x22.2x3.9x
Sun, 14 Aug 2022US$1.7tUS$403.0bUS$70.5b15.1x23.4x4.1x
Tue, 12 Jul 2022US$1.7tUS$392.4bUS$65.1b22x26.2x4.3x
Thu, 09 Jun 2022US$1.7tUS$392.5bUS$64.7b22.2x26.1x4.3x
Sat, 07 May 2022US$1.6tUS$392.7bUS$62.9b20.5x25.7x4.1x
Mon, 04 Apr 2022US$1.7tUS$373.8bUS$60.3b21.4x27.5x4.4x
Wed, 02 Mar 2022US$1.5tUS$374.2bUS$60.1b21x25.2x4.1x
Fri, 28 Jan 2022US$1.6tUS$363.7bUS$40.7b21.6x38.4x4.3x
Sun, 26 Dec 2021US$1.7tUS$361.1bUS$37.9b22.6x43.7x4.6x
Tue, 23 Nov 2021US$1.6tUS$360.7bUS$38.2b23.5x41.3x4.4x
Thu, 21 Oct 2021US$1.5tUS$340.0bUS$24.9b21.3x61.1x4.5x
Sat, 18 Sep 2021US$1.5tUS$337.6bUS$25.9b22.9x57.7x4.4x
Mon, 16 Aug 2021US$1.6tUS$338.5bUS$25.8b21x62.7x4.8x
Mon, 31 May 2021US$1.5tUS$323.4bUS$21.4b20.5x68.9x4.6x
Thu, 04 Mar 2021US$1.4tUS$304.8bUS$15.6b24x88.9x4.5x
Sun, 06 Dec 2020US$1.3tUS$284.8bUS$25.5b20.6x51.2x4.6x
Wed, 09 Sep 2020US$1.3tUS$279.3bUS$31.3b24.9x41.9x4.7x
Price to Earnings Ratio

39.3x


Total Market Cap: US$1.2tTotal Earnings: US$31.3bTotal Revenue: US$279.3bTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Pharma Industry Price to Earnings3Y Average 43.6x202120222023
Current Industry PE
  • Investors are pessimistic on the American Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 28.3x which is lower than its 3-year average PE of 43.6x.
  • The industry is trading close to its 3-year average PS ratio of 4.4x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 25% per year over the last three years.
  • Revenues for these companies have grown 12% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Comparison

How does U.S. Pharma compare with similar industries?

US Market2.47%
Healthcare2.89%
Pharma2.98%
Pharma2.98%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
JNJ Johnson & JohnsonUS$158.522.2%
+US$9.7b
-10.6%PE34.9x
LLY Eli LillyUS$436.371.6%
+US$6.6b
39.2%PE72.8x
PFE PfizerUS$38.892.3%
+US$4.9b
-27.3%PE7.6x
BMY Bristol-Myers SquibbUS$65.161.1%
+US$1.5b
-14.5%PE18.7x
VTRS ViatrisUS$9.716.1%
+US$671.5m
-18.1%PE6.1x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

JNJ

US$158.52

Johnson & Johnson

7D

2.2%

1Y

-10.6%

MRK

US$108.61

Merck

7D

-1.6%

1Y

21.4%

LLY

US$436.37

Eli Lilly

7D

1.6%

1Y

39.2%

PROC

US$4.39

Procaps Group

7D

-3.5%

1Y

-51.9%

PRPH

US$8.35

ProPhase Labs

7D

-12.0%

1Y

-26.3%

BMY

US$65.16

Bristol-Myers Squibb

7D

1.1%

1Y

-14.5%

PCRX

US$37.54

Pacira BioSciences

7D

-1.3%

1Y

-36.8%

PFE

US$38.89

Pfizer

7D

2.3%

1Y

-27.3%

COLL

US$21.38

Collegium Pharmaceutical

7D

-3.1%

1Y

31.8%

ITCI

US$65.13

Intra-Cellular Therapies

7D

9.7%

1Y

13.1%

VTRS

US$9.71

Viatris

7D

6.1%

1Y

-18.1%

CTLT

US$39.96

Catalent

7D

7.3%

1Y

-63.9%

BLTE

US$15.15

Belite Bio

7D

-8.1%

1Y

-4.1%

ELAN

US$9.38

Elanco Animal Health

7D

15.1%

1Y

-61.1%

VRNA

US$20.69

Verona Pharma

7D

-3.9%

1Y

314.6%